Tredence Acquires KMK Consulting to Expand Healthcare and Life Sciences Business

June 23, 2026
Tredence has acquired KMK Consulting, a New Jersey-based analytics and consulting firm serving major pharmaceutical companies, to accelerate growth in healthcare and life sciences. The company expects the sector to contribute 25% of its revenue by 2028.

Tredence announced in a press release the acquisition of KMK Consulting, an analytics and consulting firm based in Morris Plains, New Jersey. KMK works with eight of the world's top ten pharmaceutical companies and brings over two decades of expertise in life sciences, biopharma analytics, real world evidence, and market research.

The acquisition strengthens Tredence's position in the healthcare and life sciences sector, which the company expects to account for about 25 percent of its total revenue by 2028. Tredence plans to combine its agentic AI capabilities with KMK's domain knowledge to enhance services across the pharmaceutical value chain, from research and development to commercial launch.

Tredence stated that the combined entity will streamline processes and accelerate value creation for life sciences clients by integrating applied AI, data engineering, and decision intelligence. The deal also enhances Tredence's presence within the Veeva ecosystem, a leading cloud-based CRM and data platform used by most pharmaceutical companies worldwide.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI AI Funding News AI Brief AI Brief (X)

More from: Enterprise

06/23
Inspira Enterprise Expands Partnership with ServiceNow to Deliver Full Platform Capabilities
06/23
Geekplus Invests in J-Elephant to Expand Pallet Warehouse Automation
06/23
DocPro Expands Ask.Legal with English Law Analytics
06/23
MasOrange Selects Polystar for AI Analytics Across Combined Mobile Network
06/23
Geely Farizon, WeRide, and Kwoon Chung to Develop Right-Hand-Drive Robotaxis in Hong Kong

More from: Funding

06/23
Insilico Medicine and SK Biopharmaceuticals Sign $2.5 Billion AI Drug Discovery Deal
06/23
H3 Zoom Closes $3.6 Million Series A to Expand AI Inspection Across Asia
06/23
ChemT Biotechnology Raises $4 Million Seed Round for AI in Biomanufacturing
06/23
ECARX to Acquire Full Flyme Software Business for USD 266 Million
06/23
DropGenie Raises Seed+ Round to Launch Miniaturized Gene Editing Platform

Subscribe to AI Funding Brief

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like